Skip to content
777 Sourcing.

Capability

commercialization of hospital-use therapies

Suppliers
1
States & provinces
1
Countries
1

1 commercialization of hospital-use therapies supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ALTATHERA PHARMACEUTICALS LLC

CHICAGO, IL

AltaThera Pharmaceuticals is a Chicago, Illinois-based cardiovascular medicine company that develops and commercializes hospital-use intravenous therapies for serious cardiac arrhythmias, including atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias in adult and pediatric patients. Its product Sotalol IV (sotalol hydrochloride injection) received FDA approval in July 2025 for a pediatric label expansion.

clinical researchintravenous drug developmentpharmacometric modeling

Compiled from public sources

Related capabilities

Other processes offered by the shops that list commercialization of hospital-use therapies.

Browse all capabilities